"
Team:GeorgiaTech/Ethics and Safety
From 2010.igem.org
(Difference between revisions)
Aschwartz9 (Talk | contribs) |
|||
| (7 intermediate revisions not shown) | |||
| Line 3: | Line 3: | ||
<style type="text/css"> | <style type="text/css"> | ||
<!-- | <!-- | ||
| + | |||
| + | a, a:hover, a:visited{ | ||
| + | color: white; | ||
| + | font-weight: bold; | ||
| + | text-decoration: underline; | ||
| + | } | ||
| + | a:hover { | ||
| + | color: black; | ||
| + | } | ||
body | body | ||
| Line 77: | Line 86: | ||
<p><center><font color="#FFFFFF" size=5><b>Safety Training</b></font></center></p> | <p><center><font color="#FFFFFF" size=5><b>Safety Training</b></font></center></p> | ||
| - | < | + | <table width="965" border="0" cellpadding="0" cellspacing="0"> |
| - | <table border="2" cellpadding ="5" cellspacing = "5"> | + | <tr> |
| + | <td bgcolor="#7c1212" width="965"><font color="#FFFFFF"><p></p></font></td> | ||
| + | </tr> | ||
| + | </table> | ||
| + | |||
| + | <center><table border="2" cellpadding ="5" cellspacing = "5"> | ||
<tr><th><FONT COLOR="#FFFFFF">Team Member</FONT></th><th><FONT COLOR="#FFFFFF">Training</FONT></th></tr> | <tr><th><FONT COLOR="#FFFFFF">Team Member</FONT></th><th><FONT COLOR="#FFFFFF">Training</FONT></th></tr> | ||
| + | <tr><td><FONT COLOR="#FFFFFF">Mitesh Agrawal</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
| + | <tr><td><FONT COLOR="#FFFFFF">Margo Clark</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
| + | <tr><td><FONT COLOR="#FFFFFF">Robert Fee</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
| + | <tr><td><FONT COLOR="#FFFFFF">Christina Graves</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
<tr><td><FONT COLOR="#FFFFFF">Atta Hassan</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | <tr><td><FONT COLOR="#FFFFFF">Atta Hassan</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
| + | <tr><td><FONT COLOR="#FFFFFF">Scott Holmes</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
| + | <tr><td><FONT COLOR="#FFFFFF">Monica Huynh</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
| + | <tr><td><FONT COLOR="#FFFFFF">Gita Mahmoudabadi</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
| + | <tr><td><FONT COLOR="#FFFFFF">Christian Mandrycky</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
<tr><td><FONT COLOR="#FFFFFF">Debika Mitra</FONT></td><td><FONT COLOR="#FFFFFF">MSE Safety Training</FONT></td></tr> | <tr><td><FONT COLOR="#FFFFFF">Debika Mitra</FONT></td><td><FONT COLOR="#FFFFFF">MSE Safety Training</FONT></td></tr> | ||
| - | <tr><td><FONT COLOR="#FFFFFF">Amy Schwartz</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | + | <tr><td><FONT COLOR="#FFFFFF">Amy Schwartz</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> |
| - | <tr><td><FONT COLOR="#FFFFFF"> | + | <tr><td><FONT COLOR="#FFFFFF">Shadeah Suleiman</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
<tr><td><FONT COLOR="#FFFFFF">Sid Tantia</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | <tr><td><FONT COLOR="#FFFFFF">Sid Tantia</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
| - | + | </table> </center> | |
| - | + | ||
<p> | <p> | ||
Note: Marc Pline is from the GT School of Biology | Note: Marc Pline is from the GT School of Biology | ||
| Line 124: | Line 141: | ||
<li>environmental safety?</li> | <li>environmental safety?</li> | ||
</ul></b> | </ul></b> | ||
| - | <p> | + | <p>The Georgia Tech iGem project involves bacterial thermogenesis via cloning of a naturally occuring plant gene. All genetic parts involved are found currently in natural plants or bacteria and none pose a threat to environmental, public, or researcher safety. All bacteria strains used are nonpathogenic. Further, it is highly unlikely that genes under experimentation would cause adverse effects even if expressed in wild type bacterial colonies, as the heat production is both benign and extremely energy intensive, which would be a highly unfavorable trait. All laboratory materials, both biological and chemical, are safely used in a Biosafety Level 1 laboratory setting.</p> |
| - | + | ||
| - | + | ||
| - | is | + | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | used in a Biosafety Level 1 laboratory setting.</p> | + | |
<p><b>2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,</p> | <p><b>2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,</p> | ||
| Line 140: | Line 150: | ||
</ul></b> | </ul></b> | ||
| - | <p> | + | <p>The BioBrick device constructs contain an alternative oxidase gene (AOX) attached to a targeting sequence (OmpA) with a promoter, HybB; none of these known biosafety issues.</p> |
| - | promoter, HybB | + | |
<p><b>3. Is there a local biosafety group, committee, or review board at your institution?</p> | <p><b>3. Is there a local biosafety group, committee, or review board at your institution?</p> | ||
| Line 151: | Line 160: | ||
</ul></b> | </ul></b> | ||
| - | <p>The Occupational Health and Safety Committee and the Environmental Health and Safety Office | + | <p>The Occupational Health and Safety Committee and the Environmental Health and Safety Office of the Georgia Institute of Technology has approved Professor Eric Gaucher’s laboratory for Biosafety Level 1 Research.</p> |
| - | of the Georgia Institute of Technology has approved Professor Eric Gaucher’s laboratory for | + | |
| - | Biosafety Level 1 Research.</p> | + | |
<p><b>4. Do you have any other ideas how to deal with safety issues that could be useful for future | <p><b>4. Do you have any other ideas how to deal with safety issues that could be useful for future | ||
| Line 159: | Line 166: | ||
biosafety engineering?</p></b> | biosafety engineering?</p></b> | ||
| - | <p>Our group has discussed the sharp learning curve associated with the first year of a team’s experience | + | <p>Our group has discussed the sharp learning curve associated with the first year of a team’s experience with iGEM. All group members attended an institute biological laboratory safety class, but many things were learned along the way, specific to genetic engineering research. We would propose a collaboration of iGEM members to produce an online, visual, one-hour introductory course on the basic biosafety issues that could arise during the iGEM research process.</p> |
| - | with iGEM. | + | |
| - | + | ||
| - | genetic engineering | + | |
| - | online, visual, one-hour introductory course on the basic biosafety issues that could arise during the | + | |
| - | iGEM research process.</p> | + | |
</tr> | </tr> | ||
</table></center> | </table></center> | ||
| + | |||
<table width="965" border="0" cellpadding="0" cellspacing="0"> | <table width="965" border="0" cellpadding="0" cellspacing="0"> | ||
Latest revision as of 02:42, 28 October 2010
| Team Member | Training |
|---|---|
| Mitesh Agrawal | Marc Pline's Bio Safety Training |
| Margo Clark | Marc Pline's Bio Safety Training |
| Robert Fee | Marc Pline's Bio Safety Training |
| Christina Graves | Marc Pline's Bio Safety Training |
| Atta Hassan | Marc Pline's Bio Safety Training |
| Scott Holmes | Marc Pline's Bio Safety Training |
| Monica Huynh | Marc Pline's Bio Safety Training |
| Gita Mahmoudabadi | Marc Pline's Bio Safety Training |
| Christian Mandrycky | Marc Pline's Bio Safety Training |
| Debika Mitra | MSE Safety Training |
| Amy Schwartz | Marc Pline's Bio Safety Training |
| Shadeah Suleiman | Marc Pline's Bio Safety Training |
| Sid Tantia | Marc Pline's Bio Safety Training |
Note: Marc Pline is from the GT School of Biology
1. Would any of your project ideas raise safety issues in terms of:
The Georgia Tech iGem project involves bacterial thermogenesis via cloning of a naturally occuring plant gene. All genetic parts involved are found currently in natural plants or bacteria and none pose a threat to environmental, public, or researcher safety. All bacteria strains used are nonpathogenic. Further, it is highly unlikely that genes under experimentation would cause adverse effects even if expressed in wild type bacterial colonies, as the heat production is both benign and extremely energy intensive, which would be a highly unfavorable trait. All laboratory materials, both biological and chemical, are safely used in a Biosafety Level 1 laboratory setting. 2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,
The BioBrick device constructs contain an alternative oxidase gene (AOX) attached to a targeting sequence (OmpA) with a promoter, HybB; none of these known biosafety issues. 3. Is there a local biosafety group, committee, or review board at your institution?
The Occupational Health and Safety Committee and the Environmental Health and Safety Office of the Georgia Institute of Technology has approved Professor Eric Gaucher’s laboratory for Biosafety Level 1 Research. 4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering? Our group has discussed the sharp learning curve associated with the first year of a team’s experience with iGEM. All group members attended an institute biological laboratory safety class, but many things were learned along the way, specific to genetic engineering research. We would propose a collaboration of iGEM members to produce an online, visual, one-hour introductory course on the basic biosafety issues that could arise during the iGEM research process. |
